Sanofi taps new startup ScionxBio for long-acting RNA

ScionxBio has inked a deal with French drugmaker Sanofi — its first partnership since splitting from parent company Eleven Therapeutics a few months ago. Under the agreement, ScionxBio will screen Sanofi’s mRNA candidates through its so-called ...